Clinical Trials Directory

Trials / Unknown

UnknownNCT03198611

Reversibility of Diastolic Disfunction in Septic Shock

Early Reversibility of Diastolic Disfunction as a Prognostic Factor in Septic Shock

Status
Unknown
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Objectives: To study the prognostic value of the evolution of diastolic function according to fluid balance in patients admitted to the ICU with a diagnosis of septic shock, in terms of mortality (ICU and hospital) and mortality at 90 days. 2.4. Secondary objectives: A) Incidence and reversibility of myocardial dysfunction (left ventricular systolic and diastolic) in septic shock. B) Incidence and reversibility of diastolic dysfunction according to the echocardiographic criterion used. C) Incidence and reversibility of right ventricular systolic dysfunction.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiographyUsual echocardiographic studies in patients suffering septic shock

Timeline

Start date
2018-03-01
Primary completion
2019-01-01
Completion
2019-04-01
First posted
2017-06-26
Last updated
2018-03-06

Locations

5 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT03198611. Inclusion in this directory is not an endorsement.

Reversibility of Diastolic Disfunction in Septic Shock (NCT03198611) · Clinical Trials Directory